# Evaluation of Tumor and Blood Immune Biomarkers in Resected Non-small Cell Lung Cancer

> **NCT02848872** · — · COMPLETED · sponsor: **Duke University** · enrollment: 25 (actual)

## Conditions studied

- Non-small Cell Lung Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02848872
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2019-04-02
- **Final completion:** 2019-04-02
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2019-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02848872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02848872, "Evaluation of Tumor and Blood Immune Biomarkers in Resected Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02848872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*